FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024682110> ?p ?o ?g. }

• W2024682110 endingPage "342" @default.
• W2024682110 startingPage "332" @default.
• W2024682110 abstract "The hepatocyte growth factor/scatter factor (HGF/SF) tyrosine kinase (TK) receptor c-Met plays a crucial role in the development of the invasive phenotype of tumors and thus represents an attractive candidate for targeted therapies in a variety of malignancies, including human malignant melanoma (MM). In contrast to what has been shown previously, we were not able to detect any genetic alterations, either in the juxtamembrane- or in the TK-domain of c-Met, in the studied MM cell lines. Nevertheless, c-Met was constitutively active in these cell lines without exogenous HGF/SF stimulation. The active receptor was localized to the adhesion sites of the cells. Addition of the c-Met TK inhibitor SU11274 specifically decreased the phosphotyrosine signal at the focal adhesion sites, which was accompanied by a decrease in cell proliferation as well as an increase in apoptotic cells. In addition, non-apoptotic concentrations of SU11274 significantly reduced the in vitro migratory capacity of MM cells in the modified Boyden-chamber assay. Administration of SU11274 significantly decreased primary tumor growth as well as the capacity for liver colony formation of MM cells in SCID mice. Our study provides the first evidence for an in vivo antitumor activity of SU11274 in a human melanoma xenograft model, and suggests c-Met as a valid target for the therapy of MM. Consequently, SU11274 treatment might represent a useful strategy for controlling melanoma progression and metastasis in patients with MM. Keywords: c-Met, tyrosine kinase inhibitor, SU11274, metastasis, human malignant melanoma" @default.
• W2024682110 created "2016-06-24" @default.
• W2024682110 creator A5000161901 @default.
• W2024682110 creator A5007718548 @default.
• W2024682110 creator A5018388032 @default.
• W2024682110 creator A5021796062 @default.
• W2024682110 creator A5023494939 @default.
• W2024682110 creator A5027647977 @default.
• W2024682110 creator A5030233937 @default.
• W2024682110 creator A5030772258 @default.
• W2024682110 creator A5034346076 @default.
• W2024682110 creator A5048907232 @default.
• W2024682110 creator A5057244028 @default.
• W2024682110 creator A5067140213 @default.
• W2024682110 creator A5079287831 @default.
• W2024682110 creator A5080627990 @default.
• W2024682110 creator A5082433171 @default.
• W2024682110 creator A5087733242 @default.
• W2024682110 creator A5091224882 @default.
• W2024682110 date "2010-05-01" @default.
• W2024682110 modified "2023-10-12" @default.
• W2024682110 title "Inhibition of c-Met with the Specific Small Molecule Tyrosine Kinase Inhibitor SU11274 Decreases Growth and Metastasis Formation of Experimental Human Melanoma" @default.
• W2024682110 doi "https://doi.org/10.2174/156800910791190184" @default.
• W2024682110 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20370683" @default.
• W2024682110 hasPublicationYear "2010" @default.
• W2024682110 type Work @default.
• W2024682110 sameAs 2024682110 @default.
• W2024682110 citedByCount "30" @default.
• W2024682110 countsByYear W20246821102012 @default.
• W2024682110 countsByYear W20246821102013 @default.
• W2024682110 countsByYear W20246821102014 @default.
• W2024682110 countsByYear W20246821102015 @default.
• W2024682110 countsByYear W20246821102016 @default.
• W2024682110 countsByYear W20246821102017 @default.
• W2024682110 countsByYear W20246821102018 @default.
• W2024682110 countsByYear W20246821102019 @default.
• W2024682110 countsByYear W20246821102020 @default.
• W2024682110 countsByYear W20246821102021 @default.
• W2024682110 countsByYear W20246821102022 @default.
• W2024682110 countsByYear W20246821102023 @default.
• W2024682110 crossrefType "journal-article" @default.
• W2024682110 hasAuthorship W2024682110A5000161901 @default.
• W2024682110 hasAuthorship W2024682110A5007718548 @default.
• W2024682110 hasAuthorship W2024682110A5018388032 @default.
• W2024682110 hasAuthorship W2024682110A5021796062 @default.
• W2024682110 hasAuthorship W2024682110A5023494939 @default.
• W2024682110 hasAuthorship W2024682110A5027647977 @default.
• W2024682110 hasAuthorship W2024682110A5030233937 @default.
• W2024682110 hasAuthorship W2024682110A5030772258 @default.
• W2024682110 hasAuthorship W2024682110A5034346076 @default.
• W2024682110 hasAuthorship W2024682110A5048907232 @default.
• W2024682110 hasAuthorship W2024682110A5057244028 @default.
• W2024682110 hasAuthorship W2024682110A5067140213 @default.
• W2024682110 hasAuthorship W2024682110A5079287831 @default.
• W2024682110 hasAuthorship W2024682110A5080627990 @default.
• W2024682110 hasAuthorship W2024682110A5082433171 @default.
• W2024682110 hasAuthorship W2024682110A5087733242 @default.
• W2024682110 hasAuthorship W2024682110A5091224882 @default.
• W2024682110 hasConcept C101544691 @default.
• W2024682110 hasConcept C121608353 @default.
• W2024682110 hasConcept C126322002 @default.
• W2024682110 hasConcept C170493617 @default.
• W2024682110 hasConcept C185592680 @default.
• W2024682110 hasConcept C2776996007 @default.
• W2024682110 hasConcept C2777658100 @default.
• W2024682110 hasConcept C2778820342 @default.
• W2024682110 hasConcept C2779013556 @default.
• W2024682110 hasConcept C42362537 @default.
• W2024682110 hasConcept C502942594 @default.
• W2024682110 hasConcept C55493867 @default.
• W2024682110 hasConcept C62112901 @default.
• W2024682110 hasConcept C62478195 @default.
• W2024682110 hasConcept C71924100 @default.
• W2024682110 hasConcept C86803240 @default.
• W2024682110 hasConcept C95444343 @default.
• W2024682110 hasConceptScore W2024682110C101544691 @default.
• W2024682110 hasConceptScore W2024682110C121608353 @default.
• W2024682110 hasConceptScore W2024682110C126322002 @default.
• W2024682110 hasConceptScore W2024682110C170493617 @default.
• W2024682110 hasConceptScore W2024682110C185592680 @default.
• W2024682110 hasConceptScore W2024682110C2776996007 @default.
• W2024682110 hasConceptScore W2024682110C2777658100 @default.
• W2024682110 hasConceptScore W2024682110C2778820342 @default.
• W2024682110 hasConceptScore W2024682110C2779013556 @default.
• W2024682110 hasConceptScore W2024682110C42362537 @default.
• W2024682110 hasConceptScore W2024682110C502942594 @default.
• W2024682110 hasConceptScore W2024682110C55493867 @default.
• W2024682110 hasConceptScore W2024682110C62112901 @default.
• W2024682110 hasConceptScore W2024682110C62478195 @default.
• W2024682110 hasConceptScore W2024682110C71924100 @default.
• W2024682110 hasConceptScore W2024682110C86803240 @default.
• W2024682110 hasConceptScore W2024682110C95444343 @default.
• W2024682110 hasIssue "3" @default.
• W2024682110 hasLocation W20246821101 @default.
• W2024682110 hasLocation W20246821102 @default.
• W2024682110 hasOpenAccess W2024682110 @default.
• W2024682110 hasPrimaryLocation W20246821101 @default.
• W2024682110 hasRelatedWork W1426393029 @default.

• next